Southeast Asset Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$732K Buy
2,079
+4
+0.2% +$1.43K 0.08% 115
2025
Q4
$679K Buy
2,075
+220
+12% +$69.8K 0.06% 124
2025
Q3
$524K Hold
1,855
0.06% 132
2025
Q2
$518K Hold
1,855
0.06% 125
2025
Q1
$578K Buy
1,855
+595
+47% +$176K 0.07% 116
2024
Q4
$328K Buy
1,260
+184
+17% +$54.6K 0.04% 137
2024
Q3
$347K Hold
1,076
0.04% 133
2024
Q2
$336K Hold
1,076
0.04% 132
2024
Q1
$306K Buy
1,076
+1
+0.1% +$293 0.04% 141
2023
Q4
$310K Hold
1,075
0.04% 133
2023
Q3
$289K Hold
1,075
0.04% 128
2023
Q2
$239K Buy
1,075
+1
+0.1% +$232 0.03% 142
2023
Q1
$260K Hold
1,074
0.04% 130
2022
Q4
$282K Hold
1,074
0.04% 116
2022
Q3
$242K Buy
1,074
+1
+0.1% +$242 0.04% 122
2022
Q2
$261K Hold
1,073
0.04% 123
2022
Q1
$259K Hold
1,073
0.03% 134
2021
Q4
$241K Sell
1,073
-358
-25% -$75.6K 0.03% 135
2021
Q3
$304K Buy
1,431
+398
+39% +$91.6K 0.05% 117
2021
Q2
$252K Buy
1,033
+1
+0.1% +$246 0.04% 123
2021
Q1
$257K Hold
1,032
0.05% 118
2020
Q4
$237K Hold
1,032
0.05% 118
2020
Q3
$262K Buy
+1,032
New +$256K 0.06% 106
2019
Q1
Sell
-1,057
Closed -$206K 113
2018
Q4
$206K Buy
1,057
+1
+0.1% +$195 0.06% 106
2018
Q3
$219K Buy
+1,056
New +$208K 0.06% 103

Other funds holding AMGN

Southeast Asset Advisors's AMGN Position: Q1 2026 in Review

Southeast Asset Advisors increased its Amgen (AMGN) stake by 0.19% in Q1 2026, buying an estimated $1.43K and bringing the position to 2,079 shares worth $732K. The position accounts for 0.08% of the portfolio, ranked #115.

Southeast Asset Advisors first reported a position in AMGN in Q3 2018 and has held it in 25 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Southeast Asset Advisors held 2,079 shares of Amgen worth $732K as of Q1 2026.
  • Southeast Asset Advisors bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.08% of Southeast Asset Advisors's portfolio in Q1 2026, its #115 holding.
  • Southeast Asset Advisors first reported a position in Amgen in Q3 2018 and has held it in 25 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Southeast Asset Advisors's 13F filing for Q1 2026, filed 13 May 2026.